Drug Profile
R 1500
Alternative Names: R-1500Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antidementias
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Alzheimer's-disease in Europe
- 25 Nov 2003 Phase-I clinical trials in Alzheimer's disease in Europe (unspecified route)